Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 103 is a non-functional genetic element within the human genome classified as a rRNA processed pseudogene. It is derived from the 5S ribosomal RNA gene but does not produce functional rRNA. While the parental 5S rRNA gene is essential for the large ribosomal subunit function in protein synthesis[1][3], pseudogenes such as RNA5SP103 typically arise through retrotransposition, lose their original function, and may be transcribed at low or undetectable levels[2][4][6]. Some pseudogenes exhibit minor regulatory capacities—such as acting as miRNA decoys or producing non-coding RNA with potential interference activity—but these functions are rare and poorly characterized for 5S rRNA pseudogenes[4]. RNA, 5S ribosomal pseudogene 103 is not recognized as a receptor, enzyme, transporter, or therapeutic target, and is not relevant for disease association, biomarker, or drug targeting efforts.\n\nIf you are seeking information for actionable or druggable targets, 5S rRNA itself is a structural RNA and not targeted for therapy; the pseudogene variant RNA5SP103 is simply an inert genomic locus[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 103 (RNA5SP103).